Francesc Casellas

22.7k total citations · 2 hit papers
194 papers, 6.6k citations indexed

About

Francesc Casellas is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Francesc Casellas has authored 194 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Genetics, 106 papers in Epidemiology and 68 papers in Surgery. Recurrent topics in Francesc Casellas's work include Inflammatory Bowel Disease (110 papers), Microscopic Colitis (89 papers) and Eosinophilic Esophagitis (23 papers). Francesc Casellas is often cited by papers focused on Inflammatory Bowel Disease (110 papers), Microscopic Colitis (89 papers) and Eosinophilic Esophagitis (23 papers). Francesc Casellas collaborates with scholars based in Spain, France and United States. Francesc Casellas's co-authors include Natalia Borruel, Francisco Guarner, Chaysavanh Manichanh, J. R. Malagelada, Maria Antolı́n, Encarna Varela, Antonio Torrejón, Juan‐Ramón Malagelada, J Vilaseca and J.‐R. Malagelada and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Francesc Casellas

184 papers receiving 6.4k citations

Hit Papers

The gut microbiota in IBD 2012 2026 2016 2021 2012 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesc Casellas Spain 39 3.1k 2.5k 2.2k 1.7k 1.4k 194 6.6k
R. D’Incà Italy 49 3.6k 1.2× 2.5k 1.0× 1.6k 0.7× 2.1k 1.2× 784 0.5× 229 7.5k
Richard B. Gearry New Zealand 52 4.5k 1.4× 3.2k 1.3× 1.3k 0.6× 2.5k 1.5× 1.5k 1.1× 311 9.5k
Joshua R. Korzenik United States 47 5.6k 1.8× 4.3k 1.7× 3.3k 1.5× 2.7k 1.6× 1.1k 0.7× 176 11.4k
Anthony Otley Canada 43 4.4k 1.4× 3.1k 1.2× 1.2k 0.6× 1.8k 1.1× 530 0.4× 167 6.8k
David S. Rampton United Kingdom 51 2.7k 0.9× 2.0k 0.8× 1.1k 0.5× 2.2k 1.4× 1.0k 0.7× 128 7.8k
Wolfgang Kruis Germany 42 2.9k 0.9× 2.0k 0.8× 1.6k 0.7× 2.4k 1.5× 1.4k 1.0× 208 7.1k
Neal S. LeLeiko United States 40 2.8k 0.9× 2.0k 0.8× 2.3k 1.0× 1.6k 1.0× 527 0.4× 163 6.7k
Andrew S. Day New Zealand 51 3.6k 1.2× 2.6k 1.0× 1.7k 0.8× 3.0k 1.8× 891 0.6× 353 8.4k
Whitney Tang Hong Kong 15 3.4k 1.1× 2.1k 0.8× 1.7k 0.8× 1.5k 0.9× 483 0.3× 28 5.6k
Ailsa Hart United Kingdom 56 5.6k 1.8× 3.9k 1.6× 4.0k 1.8× 3.5k 2.1× 1.2k 0.9× 327 12.6k

Countries citing papers authored by Francesc Casellas

Since Specialization
Citations

This map shows the geographic impact of Francesc Casellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Casellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Casellas more than expected).

Fields of papers citing papers by Francesc Casellas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Casellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Casellas. The network helps show where Francesc Casellas may publish in the future.

Co-authorship network of co-authors of Francesc Casellas

This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Casellas. A scholar is included among the top collaborators of Francesc Casellas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Casellas. Francesc Casellas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayorga, L, Joaquím Roca, Natalia Borruel, et al.. (2021). Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. Computational and Structural Biotechnology Journal. 19. 6481–6489. 38 indexed citations
2.
Casellas, Francesc, et al.. (2021). Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue. BMC Gastroenterology. 21(1). 412–412. 5 indexed citations
3.
Borruel, Natalia, Virginia Robles, Claudia Herrera‐deGuise, et al.. (2021). Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease. Gastroenterología y Hepatología. 44(7). 481–488. 8 indexed citations
4.
Casellas, Francesc, Ascensión Marcos, Javier Santos, et al.. (2018). Consensus document on exclusion diets in irritable bowel syndrome (IBS). Revista Española de Enfermedades Digestivas. 110(12). 806–824. 5 indexed citations
5.
Pascal, Victoria, Marta Pozuelo, Natalia Borruel, et al.. (2017). A microbial signature for Crohn's disease. Gut. 66(5). 813–822. 595 indexed citations breakdown →
6.
Vergara, Mercedes, Beatriz Sicilia, Luís Prieto, et al.. (2016). Development and Validation of the Short Crohnʼs Disease Work Disability Questionnaire. Inflammatory Bowel Diseases. 22(4). 955–962. 7 indexed citations
7.
Casellas, Francesc, et al.. (2016). Patient preferences for inflammatory bowel disease treatment objectives. Digestive and Liver Disease. 49(2). 152–156. 48 indexed citations
8.
Panda, Suchita, Francesc Casellas, J Vivancos, et al.. (2014). Short-Term Effect of Antibiotics on Human Gut Microbiota. PLoS ONE. 9(4). e95476–e95476. 267 indexed citations
9.
Ginard, Daniel, Sam Khorrami, Ignacio Marı́n, et al.. (2012). P252 Effectiveness and safety of ustekinumab as rescue therapy in multi-drug resistant Crohn's disease. Journal of Crohn s and Colitis. 6. S109–S110. 2 indexed citations
10.
Casellas, Francesc, et al.. (2012). Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment. Journal of Crohn s and Colitis. 6(9). 881–886. 25 indexed citations
11.
Casellas, Francesc, Manuel Barreiro‐de Acosta, Marta Iglesias, et al.. (2012). Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 24(7). 762–769. 77 indexed citations
12.
Vergara, Mercedes, Antónia Montserrat, Francesc Casellas, et al.. (2011). Development and validation of the Crohnʼs disease perceived work disability questionnaire. Inflammatory Bowel Diseases. 17(11). 2350–2357. 21 indexed citations
13.
Vergara, Mercedes, Antónia Montserrat, Francesc Casellas, et al.. (2011). A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version. Value in Health. 14(6). 859–861. 27 indexed citations
14.
Martínez, Cristina, Maria Antolı́n, Javier Santos, et al.. (2008). Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission. The American Journal of Gastroenterology. 103(3). 643–648. 160 indexed citations
15.
Casellas, Francesc, et al.. (2008). Claroscuros en la enfermedad celiaca. Revista Española de Enfermedades Digestivas. 100(1). 1–4. 2 indexed citations
16.
Casellas, Francesc, Luı́s Rodrigo, J Vivancos, et al.. (2008). Factors that impact health-related quality of life in adults with celiac disease: A multicenter study. World Journal of Gastroenterology. 14(1). 46–46. 102 indexed citations
17.
Casellas, Francesc, et al.. (2007). Traducción, adaptación y validación al español del cuestionario de calidad de vida de 32 ítems (IBDQ-32) de la enfermedad inflamatoria intestinal. Revista Española de Enfermedades Digestivas. 99(9). 511–9. 27 indexed citations
18.
Papo, Michel, Juan Carlos Quer, Cristina Gutiérrez, et al.. (1999). Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies. European Journal of Gastroenterology & Hepatology. 11(4). 413–420. 11 indexed citations
19.
Santos, Javier, et al.. (1995). Intravenous Cyclosporine for Steroid-Refractory Attacks of Crohnʼs Disease. Journal of Clinical Gastroenterology. 20(3). 207–210. 32 indexed citations
20.
Casellas, Francesc, Francisco Guarner, Maria Antolı́n, et al.. (1994). Abnormal leukotriene C4 released by unaffected jejunal mucosa in patients with inactive Crohn's disease.. Gut. 35(4). 517–522. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026